These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1114144)

  • 1. [Trends in the development of new drugs].
    Konieczny M
    Postepy Hig Med Dosw; 1975; 29(1):91-110. PubMed ID: 1114144
    [No Abstract]   [Full Text] [Related]  

  • 2. [Types of drug side effects and their classification].
    Davydov VF
    Farmakol Toksikol; 1980; 43(6):652-61. PubMed ID: 7450000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability.
    Nassar AE; Kamel AM; Clarimont C
    Drug Discov Today; 2004 Dec; 9(23):1020-8. PubMed ID: 15574318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.
    Dokoumetzidis A; Macheras P
    Int J Pharm; 2006 Sep; 321(1-2):1-11. PubMed ID: 16920290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The consequence of the preparation factors for the effect of the drug].
    Johnsgård M; Pedersen AO
    Tidsskr Nor Laegeforen; 1973 Apr; 93(10):698-703. PubMed ID: 4755086
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research of for the discovery of new drugs and research for the development and production of drugs].
    Setnikar I
    Boll Chim Farm; 1971 Sep; 110(9):503-9. PubMed ID: 5137987
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thoughts on the development of drugs].
    Büchi J
    Pharm Acta Helv; 1972; 47(11):676-97. PubMed ID: 4576436
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical value of the determination of drugs in the blood: a new aspect of pharmacokinetics].
    Hirtz J; Schoeller JP
    Nouv Presse Med; 1976 Mar; 5(13):869-72. PubMed ID: 1264634
    [No Abstract]   [Full Text] [Related]  

  • 9. The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs.
    Garrett ER
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):6-20. PubMed ID: 4924331
    [No Abstract]   [Full Text] [Related]  

  • 10. [A "new" mechanism behind the hypersensitive reactions to drug combinations. A report from a meeting].
    Naess K
    Tidsskr Nor Laegeforen; 1973 Jan; 93(3):183-4. PubMed ID: 4693379
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug dosage form and action].
    Zathurecký L
    Med Klin; 1974 Apr; 69(16):667-70. PubMed ID: 4837397
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of pharmaceutical profiling assays for optimization of drug-like properties.
    Di L; Kerns EH
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--drug interaction in biopharmaceutics (author's transl)].
    Arita T
    Rinsho Byori; 1975 Feb; 23(2):76-81. PubMed ID: 1168752
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of biopharmaceutics in pharmaceutical education.
    Mezei M
    Pharmazie; 1971 Nov; 26(11):656-8. PubMed ID: 5154315
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biopharmaceutical aspects of pharmaceutical technology].
    Thoma K
    Pharmazie; 1981 Mar; 36(3):185-93. PubMed ID: 7279982
    [No Abstract]   [Full Text] [Related]  

  • 17. LC/MS applications in drug development.
    Lee MS; Kerns EH
    Mass Spectrom Rev; 1999; 18(3-4):187-279. PubMed ID: 10568041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [General problems in the study of the mutagenic properties of drugs].
    Durnev AD; Volgareva GM; Seredenin SB
    Eksp Klin Farmakol; 1998; 61(2):4-12. PubMed ID: 9621164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [o- and m-dinitrobenzenes and their derivatives as reagents in the analysis of organic drugs].
    Iavorskiĭ MP
    Farm Zh; 1976; 31(5):26-9. PubMed ID: 1026485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.